NCT07379177

Evaluation of the Pharmacokinetics of Curcumin Capsules in Healthy Human

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 12 (estimated)
• Sponsor: Kingdomway (Inner Mongolia) Nutritional Food Co., Ltd. · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

Main objective: Through blood drug concentration testing, evaluate the post-meal pharmacokinetic characteristics of the curcumin product compared to similar products, and assess the differences in body exposure between the self-developed product and the control product in healthy trial participants. Secondary objective: Observe the safety of the self-developed product and the control product in healthy trial participants. Study population: Healthy male individuals or non-pregnant non-lactating females

Conditions

• Healthy

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Curcumin	In the first cycle, take 4 capsules of the self-developed product (T, Nano Curcumin Capsules) (125 mg per capsule), in the second cycle take 2 capsules of the control product (R, Curcumin Capsules) (250 mg per capsule), take with 240 mL of water, and the cleansing period is 7 days.
DIETARY_SUPPLEMENT	Nanocurcumin	In the first cycle, take 2 capsules (250mg each) of the control product (R, Curcumin Capsules). In the second cycle, take 4 capsules (125mg each) of the self-developed product (T, Nano Curcumin Capsules). Take with 240 mL of water and the cleansing period is 7 days.

Timeline

• Start date: 2026-01-28
• Primary completion: 2026-02-07
• Completion: 2026-02-28
• First posted: 2026-01-30
• Last updated: 2026-01-30

Locations

1 site across 1 country: China